¹æ±¤Á¾¾ç¿¡¼ÀÇ Thiotepa ±¹¼Ò¿ä¹ýÀÇ ÀÓ»óÀû °üÂû
A Clinical Observation of the Intravesical Thiotepa in Bladder Cancer
¼Ò¼Ó »ó¼¼Á¤º¸
¹Î±Ù½Ä/Min KS
¹Ú±ÔÈ«/Park KH
KMID : 0358319810220020195
Abstract
"Primary transitional cell carcinoma of the bladder was treated with prophylactic and therapeutic Intravesical thiotepa in 7 cases. In 5 cases of stage A tumor, postoperative follow up was averaged 10.8 months and 4 cases were tumor free (80%). In 2 cases of infiltrating tumor, the instillation was not effective. Thiotepa can be given safely in the 7 days post-operative period and no leukopenia and bladder irritation symptoms were occurred."
Å°¿öµå
¹æ±¤Á¾¾ç; ¹æ±¤³»ÈÇпä¹ý; Intravesical chemotherapy; thiotepa; bladder cancer
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸